Quarterly report · Q3
2413.TEDINET S100SS2U
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥179.2bn | 2023-04-01 → 2023-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥63.4bn | 2023-10-01 → 2023-12-31d | Cons. | Revenue IFRS |
| Revenue | ¥230.8bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥175.2bn | 2022-04-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥62.5bn | 2022-10-01 → 2022-12-31d | Cons. | Revenue IFRS |
| Operating income | ¥55.0bn | 2023-04-01 → 2023-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥20.4bn | 2023-10-01 → 2023-12-31d | Cons. | Operating profit loss IFRS |
| Operating income | ¥58.7bn | 2022-04-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥22.4bn | 2022-10-01 → 2022-12-31d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥57.3bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥20.0bn | 2023-10-01 → 2023-12-31d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥74.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥60.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥22.2bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥36.6bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥13.2bn | 2023-10-01 → 2023-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥49.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥39.3bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥15.2bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥38.9bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥13.8bn | 2023-10-01 → 2023-12-31d | Cons. | Profit loss IFRS |
| Net income | ¥41.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥15.9bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss IFRS |
| Total assets | ¥463.8bn | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥400.6bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥380.7bn | at 2022-12-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥112.7bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥91.1bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥351.1bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥309.5bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥297.4bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥264.0bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥337.1bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥302.6bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥290.7bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥143.1bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥118.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥109.8bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥104.3bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥35.6bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥57.1bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥33.4bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥26.3bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥21.9bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥8.6bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥13.9bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥22.8bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥20.7bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥53.93 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥19.45 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥72.22 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥57.86 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥22.42 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥53.89 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥19.44 | 2023-10-01 → 2023-12-31d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥72.17 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥57.82 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥22.4 | 2022-10-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 72.7% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 75.5% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 76.4% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 107
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥2.6bn |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2023-12-31 | −¥779m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥2.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2023-12-31 | −¥779m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥459m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2023-12-31 | −¥584m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥12.5bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥3.5bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥12.5bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥3.5bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥31m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥10m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥3.9bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥549m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥20.3bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥6.5bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥20.1bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥6.4bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥248m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥32m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥5.1bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥71.5bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥26.0bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥69.3bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥25.3bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥2.2bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥710m |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥30.4bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥11.9bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥52.1bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥19.5bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥52.1bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥19.5bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥15m |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥4m |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥12.9bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥5.6bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥23.4bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥23.4bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥10m |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥3m |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.6bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥842m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥179.8bn |
| —segment total | revenue | 2023-10-01 → 2023-12-31 | ¥63.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥177.3bn |
| —segment total | revenue external | 2023-10-01 → 2023-12-31 | ¥62.7bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥2.5bn |
| —segment total | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥759m |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥54.9bn |
| —segment total | segment profit | 2023-10-01 → 2023-12-31 | ¥20.5bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥3.9bn |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2022-12-31 | −¥1.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥3.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2022-12-31 | −¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2022-12-31 | −¥418m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥11.5bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥3.1bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥10.8bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥2.9bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥623m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥178m |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥4.2bn |
| jpcrp040300-q3r_E05425-000Career Solutionreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥734m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥20.6bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥6.6bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥20.1bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥6.4bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥521m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥174m |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥6.0bn |
| jpcrp040300-q3r_E05425-000Evidence Solutionreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥1.8bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥69.8bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥27.2bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥67.4bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥26.5bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥2.4bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥739m |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥32.1bn |
| jpcrp040300-q3r_E05425-000Medical Platformreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥13.3bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥47.3bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥17.1bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥47.2bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥17.1bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥21m |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥17m |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥13.9bn |
| jpcrp040300-q3r_E05425-000Overseasreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥5.8bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥27.5bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥8.8bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥27.2bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥8.8bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥304m |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥3.2bn |
| jpcrp040300-q3r_E05425-000Site Solutionreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥917m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥176.6bn |
| —segment total | revenue | 2022-10-01 → 2022-12-31 | ¥62.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥172.8bn |
| —segment total | revenue external | 2022-10-01 → 2022-12-31 | ¥61.6bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| —segment total | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥1.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥59.5bn |
| —segment total | segment profit | 2022-10-01 → 2022-12-31 | ¥22.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 773
| Item | Context | Value | Unit |
|---|---|---|---|
| Dividends ss IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | -12899000000 | JPY |
| Dividends ss IFRS | CurrentYTDDuration_NonControllingInterestsIFRSMember | -2464000000 | JPY |
| Dividends ss IFRS | CurrentYTDDuration | -15364000000 | JPY |
| Changes in ownership interest in subsidiaries ss IFRS | CurrentYTDDuration_CapitalSurplusIFRSMember | 3375000000 | JPY |
| Changes in ownership interest in subsidiaries ss IFRS | CurrentYTDDuration_OtherComponentsOfEquityIFRSMember | -128000000 | JPY |
| Changes in ownership interest in subsidiaries ss IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | 3248000000 | JPY |
| Changes in ownership interest in subsidiaries ss IFRS | CurrentYTDDuration_NonControllingInterestsIFRSMember | 7147000000 | JPY |
| Changes in ownership interest in subsidiaries ss IFRS | CurrentYTDDuration | 10395000000 | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_ShareCapitalIFRSMember | 106000000 | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_CapitalSurplusIFRSMember | 126000000 | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_OtherComponentsOfEquityIFRSMember | 121000000 | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | 354000000 | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration | 354000000 | JPY |
| Transfer from other components of equity to retained earnings ss IFRS | CurrentYTDDuration_OtherComponentsOfEquityIFRSMember | 1000000 | JPY |
| Transfer from other components of equity to retained earnings ss IFRS | CurrentYTDDuration_RetainedEarningsIFRSMember | -1000000 | JPY |
| Transfer from other components of equity to retained earnings ss IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | － | JPY |
| Transfer from other components of equity to retained earnings ss IFRS | CurrentYTDDuration | － | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_ShareCapitalIFRSMember | 106000000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_CapitalSurplusIFRSMember | 3502000000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_TreasurySharesIFRSMember | － | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_OtherComponentsOfEquityIFRSMember | -5000000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_RetainedEarningsIFRSMember | -12901000000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | -9298000000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_NonControllingInterestsIFRSMember | 4683000000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration | -4615000000 | JPY |
| Equity IFRS | CurrentQuarterInstant_ShareCapitalIFRSMember | 29298000000 | JPY |
| Equity IFRS | CurrentQuarterInstant_CapitalSurplusIFRSMember | 28583000000 | JPY |
| Equity IFRS | CurrentQuarterInstant_TreasurySharesIFRSMember | -37000000 | JPY |
| Equity IFRS | CurrentQuarterInstant_OtherComponentsOfEquityIFRSMember | 24331000000 | JPY |
| Equity IFRS | CurrentQuarterInstant_RetainedEarningsIFRSMember | 254927000000 | JPY |
| Equity IFRS | CurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember | 337102000000 | JPY |
| Equity IFRS | CurrentQuarterInstant_NonControllingInterestsIFRSMember | 14026000000 | JPY |
| Equity IFRS | CurrentQuarterInstant | 351128000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 60249000000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 57325000000 | JPY |
| Depreciation and amortization ope cf IFRS | Prior1YTDDuration | 5339000000 | JPY |
| Depreciation and amortization ope cf IFRS | CurrentYTDDuration | 6454000000 | JPY |
| Impairment losses reversal of impairment losses ope cf IFRS | Prior1YTDDuration | -820000000 | JPY |
| Impairment losses reversal of impairment losses ope cf IFRS | CurrentYTDDuration | － | JPY |
| Finance income ope cf IFRS | Prior1YTDDuration | -1561000000 | JPY |
| Finance income ope cf IFRS | CurrentYTDDuration | -2616000000 | JPY |
| Finance costs ope cf IFRS | Prior1YTDDuration | 46000000 | JPY |
| Finance costs ope cf IFRS | CurrentYTDDuration | 255000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | Prior1YTDDuration | -1299000000 | JPY |
| Share of loss profit of investments accounted for using equity method ope cf IFRS | CurrentYTDDuration | -729000000 | JPY |
| Gain on sale of affiliate company stock ope cf IFRS | Prior1YTDDuration | － | JPY |
| Gain on sale of affiliate company stock ope cf IFRS | CurrentYTDDuration | -592000000 | JPY |
| Change in financial assets measured at fair value through profit or loss ope cf IFRS | Prior1YTDDuration | -285000000 | JPY |
| Change in financial assets measured at fair value through profit or loss ope cf IFRS | CurrentYTDDuration | -1358000000 | JPY |
| Decrease increase in trade and other receivables ope cf IFRS | Prior1YTDDuration | -3515000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |